The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: TAP Pharmaceuticals
Approval Status: Approved June 1999
Treatment for: Gynecology
General Information
Lupron has been approved for the following indications: endometriosis and uterine fibroids.